Andrew Hill

Andrew Hill is not mentioned in either of the provided news articles. Therefore, it's impossible to provide a summary about him based on the given information. The articles focus on UK-US trade deals regarding pharmaceuticals and the potential for affordable weight-loss drugs. One article discusses the implications of a UK-US medicines deal, including potential impacts on the NHS and access to drugs. The other article highlights a study suggesting that weight-loss jabs like Wegovy and Ozempic could be manufactured at a significantly lower cost, potentially increasing accessibility in lower-income countries. Neither article contains any reference to a person named Andrew Hill.